GSK Scientists Knew About Zantac's Cancer Risks For Forty Years
By Herman James / February 20, 2023 / marketsanity.com / Article Link
Zero Hedge, Released on 2/20/23
Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial
GSK Scientists Knew About Zantac's Cancer Risks For Forty Years added by Herman James on 02/20/2023View all posts by Herman James ?+'
Recent News
Gold stocks reach new highs on metal price gain
August 25, 2025 / www.canadianminingreport.com
Rise in gold stocks propels TSXV Mining
August 25, 2025 / www.canadianminingreport.com
Market sees gold sector nearing full value overall after target upgrades
August 18, 2025 / www.canadianminingreport.com
Gold stocks gain even as metal pulls back
August 18, 2025 / www.canadianminingreport.com
Gold stocks rocket to new highs, valuations no longer inexpensive
August 11, 2025 / www.canadianminingreport.com